Lantern Pharma Ownership | Who Owns Lantern Pharma?

Lantern Pharma Ownership Summary

Lantern Pharma is owned by 22.47% institutional investors, 14.72% insiders, and 62.81% retail investors. Bios capital management, lp is the largest institutional shareholder, holding 11.22% of LTRN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.37% of its assets in Lantern Pharma shares.

LTRN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Lantern Pharma	22.47%	14.72%	62.81%
Sector	Healthcare Stocks	279.19%	10.58%	-189.76%
Industry	Biotech Stocks	63.97%	10.68%	25.35%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bios capital management, lp	1.21M	11.22%	$3.85M
Vanguard group	363.72K	3.38%	$1.16M
Cm management	200.00K	1.86%	$638.00K
Renaissance	87.30K	0.81%	$278.49K
Geode capital management	86.97K	0.81%	$277.52K
Newedge advisors	68.36K	0.64%	$218.07K
Voss capital	50.00K	0.46%	$159.50K
Blackrock funding, inc. /de	40.60K	0.38%	$129.50K
Blackrock	39.84K	0.37%	$186.06K
Dimensional fund advisors lp	36.55K	0.34%	$116.59K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bios capital management, lp	1.21M	4.02%	$3.85M
Cm management	200.00K	0.57%	$638.00K
Westside investment management	30.65K	0.02%	$97.78K
Voss capital	50.00K	0.01%	$159.50K
Sigma planning	28.45K	0.00%	$90.76K
Richards, merrill & peterson	975.00	0.00%	$3.11K
Newedge advisors	68.36K	0.00%	$218.07K
Perigon wealth management	14.60K	0.00%	$52.56K
Horizon kinetics asset management	28.79K	0.00%	$91.84K
Davenport	25.81K	0.00%	$82.35K

Top Buyers

Holder	Shares	% Assets	Change
Bios capital management, lp	1.21M	4.02%	1.21M
Voss capital	50.00K	0.01%	50.00K
Blackrock	39.84K	-	20.18K
Cm management	200.00K	0.57%	15.00K
Millennium management	10.13K	-	10.13K

Top Sellers

Holder	Shares	% Assets	Change
Newedge advisors	68.36K	0.00%	-68.98K
Redmond asset management	-	-	-37.27K
Davenport	25.81K	0.00%	-28.00K
Pathway financial advisors	-	-	-25.00K
Jane street group	-	-	-24.87K

New Positions

Holder	Shares	% Assets	Change	Value
Bios capital management, lp	1.21M	4.02%	1.21M	$3.85M
Voss capital	50.00K	0.01%	50.00K	$159.50K
Millennium management	10.13K	-	10.13K	$47.33K
Royal bank of canada	1.42K	-	1.42K	$7.00K
Richards, merrill & peterson	975.00	0.00%	975.00	$3.11K

Sold Out

Holder	Change
Qube research	-2.00
Federated hermes	-74.00
Cypress capital	-200.00
Stone house investment management	-200.00
Pnc financial services group	-250.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	33	-2.94%	2,423,715	-3.04%	22	4.17%	13	-7.14%	6	-40.00%
Dec 31, 2024	32	-3.03%	2,475,913	85.34%	23	14.93%	14	7.69%	10	25.00%
Sep 30, 2024	33	-19.51%	1,335,871	3.88%	12	8.66%	13	-27.78%	8	-42.86%
Jun 30, 2024	41	10.81%	1,286,036	16.02%	11	11.45%	18	-5.26%	14	40.00%
Mar 31, 2024	37	23.33%	1,108,429	1.09%	10	10.02%	19	137.50%	10	-16.67%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	256.11K	2.37%	-
Vanguard US Total Market Shares ETF	256.11K	2.37%	-
Vanguard Institutional Extnd Mkt Idx Tr	99.27K	0.92%	-
Fidelity Extended Market Index	44.06K	0.41%	-409.00
Horizon Kinetics Medical ETF	27.58K	0.26%	-
DFA US Targeted Value I	21.64K	0.20%	324.00
BlackRock Extended Equity Market K	15.56K	0.14%	-7.00
Extended Equity Market Fund K	15.40K	0.14%	47.00
Fidelity Total Market Index	15.40K	0.14%	-
iShares Micro-Cap ETF	15.04K	0.14%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 28, 2025	Fletcher Aaron G.L.	-	Sell	$15.30K
May 29, 2025	Fletcher Aaron G.L.	-	Sell	$21.76K
May 27, 2025	Fletcher Aaron G.L.	-	Sell	$19.76K
May 28, 2025	Fletcher Aaron G.L.	-	Sell	$13.26K
May 27, 2025	Fletcher Aaron G.L.	-	Sell	$22.81K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	30
2024 Q3	-	-
2024 Q2	-	12
2024 Q1	-	24
2023 Q4	-	4

LTRN Ownership FAQ

Who Owns Lantern Pharma?

Lantern Pharma shareholders are primarily institutional investors at 22.47%, followed by 14.72% insiders and 62.81% retail investors. The average institutional ownership in Lantern Pharma's industry, Biotech Stocks , is 63.97%, which Lantern Pharma falls below.

Who owns the most shares of Lantern Pharma?

Lantern Pharma’s largest shareholders are Bios capital management, lp (1.21M shares, 11.22%), Vanguard group (363.72K shares, 3.38%), and Cm management (200K shares, 1.86%). Together, they hold 16.46% of Lantern Pharma’s total shares outstanding.

Does Blackrock own Lantern Pharma?

Yes, BlackRock owns 0.37% of Lantern Pharma, totaling 39.84K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 186.06K$. In the last quarter, BlackRock increased its holdings by 20.18K shares, a 102.66% change.

Who is Lantern Pharma’s biggest shareholder by percentage of total assets invested?

Bios capital management, lp is Lantern Pharma’s biggest shareholder by percentage of total assets invested, with 4.02% of its assets in 1.21M Lantern Pharma shares, valued at 3.85M$.

Who is the top mutual fund holder of Lantern Pharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Lantern Pharma shares, with 2.37% of its total shares outstanding invested in 256.11K Lantern Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools